{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:08:03Z","timestamp":1790356083412,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10147-026-03135-7","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:25:31Z","timestamp":1784197531000},"page":"2301-2311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact of adjuvant chemotherapy and regimen selection in Stage III colorectal cancer with impaired performance status: a multicenter cohort study"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0742-8961","authenticated-orcid":false,"given":"Takuki","family":"Yagyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Uejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimitsu","family":"Tanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuro","family":"Kurisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"3","key":"3135_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3135_CR2","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1007\/s10147-025-02899-8","volume":"30","author":"Y Kinugasa","year":"2024","unstructured":"Kinugasa Y, Uehara K, Yamaguchi K et al (2024) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer. Int J Clin Oncol 30(12):2410\u20132463","journal-title":"Int J Clin Oncol"},{"key":"3135_CR3","doi-asserted-by":"crossref","unstructured":"(1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 345(8955): 939\u201344","DOI":"10.1016\/S0140-6736(95)90696-7"},{"issue":"23","key":"3135_CR4","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343\u20132351","journal-title":"N Engl J Med"},{"issue":"11","key":"3135_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J et al (2011) Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 29(11):1465\u20131471","journal-title":"J Clin Oncol"},{"issue":"12","key":"3135_CR6","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/DCR.0000000000000699","volume":"59","author":"JR Bergquist","year":"2016","unstructured":"Bergquist JR, Thiels CA, Spindler BA et al (2016) Benefit of postresection adjuvant chemotherapy for stage III colon cancer in octogenarians: analysis of the National Cancer Database. Dis Colon Rectum 59(12):1142\u20131149","journal-title":"Dis Colon Rectum"},{"issue":"21","key":"3135_CR7","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.294.21.2703","volume":"294","author":"JM Jessup","year":"2005","unstructured":"Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race\/ethnicity, age, and differentiation. JAMA 294(21):2703\u20132711","journal-title":"JAMA"},{"issue":"21","key":"3135_CR8","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","volume":"30","author":"HK Sanoff","year":"2012","unstructured":"Sanoff HK, Carpenter WR, St\u00fcrmer T et al (2012) Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol 30(21):2624\u20132634","journal-title":"J Clin Oncol"},{"issue":"2","key":"3135_CR9","first-page":"162","volume":"23","author":"S Ades","year":"2009","unstructured":"Ades S (2009) Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice. Oncology (Williston Park) 23(2):162\u2013167","journal-title":"Oncology (Williston Park)"},{"issue":"20","key":"3135_CR10","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1200\/JCO.2013.49.6638","volume":"31","author":"NJ McCleary","year":"2013","unstructured":"McCleary NJ, Meyerhardt JA, Green E et al (2013) Impact of age on the efficacy of newer adjuvant therapies in patients with stage II\/III colon cancer: findings from the ACCENT database. J Clin Oncol 31(20):2600\u20132606","journal-title":"J Clin Oncol"},{"key":"3135_CR11","doi-asserted-by":"crossref","unstructured":"Weiser MR. (2018) AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol. 25. United States. p. 1454\u20135","DOI":"10.1245\/s10434-018-6462-1"},{"key":"3135_CR12","doi-asserted-by":"crossref","unstructured":"Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. J Anus Rectum Colon. 2019; 3(4):175\u201395","DOI":"10.23922\/jarc.2019-018"},{"issue":"12","key":"3135_CR13","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S1470-2045(20)30527-1","volume":"21","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Meyerhardt J, Iveson T et al (2020) Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol 21(12):1620\u20131629","journal-title":"Lancet Oncol"},{"issue":"28","key":"3135_CR14","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","volume":"29","author":"G Yothers","year":"2011","unstructured":"Yothers G, O\u2019Connell MJ, Allegra CJ et al (2011) Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29(28):3768\u20133774","journal-title":"J Clin Oncol"},{"issue":"9","key":"3135_CR15","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","volume":"268","author":"L Kang","year":"2021","unstructured":"Kang L, Tian Y, Xu S et al (2021) Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol 268(9):3269\u20133282","journal-title":"J Neurol"},{"issue":"6","key":"3135_CR16","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s10147-025-02738-w","volume":"30","author":"S Umeda","year":"2025","unstructured":"Umeda S, Nakayama G, Kishida T et al (2025) Efficacy and safety of postoperative adjuvant chemotherapy with oxaliplatin for elderly patients: results from the CCOG-1302 study. Int J Clin Oncol 30(6):1174\u20131182","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"3135_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/jamaoncol.2021.0848","volume":"7","author":"PS Hall","year":"2021","unstructured":"Hall PS, Swinson D, Cairns DA et al (2021) Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced gastroesophageal cancer: the GO2 phase 3 randomized clinical trial. JAMA Oncol 7(6):869\u2013877","journal-title":"JAMA Oncol"},{"issue":"3","key":"3135_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00520-014-2418-6","volume":"23","author":"HW Jung","year":"2015","unstructured":"Jung HW, Kim JW, Kim JY et al (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23(3):687\u2013694","journal-title":"Support Care Cancer"},{"issue":"5","key":"3135_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/ags3.12826","volume":"8","author":"K Tatsuta","year":"2024","unstructured":"Tatsuta K, Sakata M, Kojima T et al (2024) Impact of perioperative prognostic nutritional index changes on the survival of patients with stage II\/III colorectal cancer. Ann Gastroenterol Surg 8(5):817\u2013825","journal-title":"Ann Gastroenterol Surg"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03135-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:50:27Z","timestamp":1790355027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03135-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3135"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03135-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9723302\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional review board and with the 1964 Declaration of Helsinki and its later amendments. This study was approved by the Certified Review Board of Tottori University Hospital (Approval Number: 24A100).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using an opt-out approach approved by the Institutional Ethics Committee, and the need to obtain individual informed consent was waived because this was a retrospective study of anonymized data.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}